Julia Elizabeth Thompson

Title: Innovations of Julia Elizabeth Thompson

Introduction

Julia Elizabeth Thompson is a notable inventor based in Herts, GB. She has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of three patents to her name, her work focuses on addressing critical health issues.

Latest Patents

Thompson's latest patents include innovations related to human antibodies specific for TGFβ2. These specific binding members comprise human antibody antigen binding domains that target human transforming growth factor beta (TGFβ). They bind specifically to isoforms TGFβ2 and TGFβ1, showing preferential binding compared to TGFβ3. The therapeutic utility of these antibodies is demonstrated through in vitro and in vivo models, particularly in treating fibrotic diseases and immune/inflammatory conditions. Detailed sequence and binding information is provided, including epitope sequence data for specific binding members that neutralize the active form of TGFβ2 without affecting its latent form.

Career Highlights

Throughout her career, Julia has worked with prominent organizations such as Cambridge Antibody Technology Limited and the Medical Research Council. Her contributions have been pivotal in advancing research in antibody therapies.

Collaborations

Some of her notable coworkers include Alison Jane Wilton and Philip Ronald Tempest. Their collaborative efforts have further enhanced the impact of her research.

Conclusion

Julia Elizabeth Thompson's innovative work in the field of biotechnology, particularly in the development of specific antibodies, showcases her significant contributions to medical science. Her patents reflect a commitment to addressing complex health challenges through targeted therapies.